Prostate Cancer Research Study
Clinic: John B. Amos Cancer Center
Location: Columbus, GA
Prostate cancer is the most common cancer among men and the second most common cause of cancer-related deaths among American men. African-American men are more likely to get prostate cancer and twice as likely to die from the disease. The prostate is part of the male reproductive system that makes semen. The walnut-sized gland is located beneath the bladder and surrounds the upper part of the urethra, the tube that carries urine from the bladder.
The primary objective of this study is to demonstrate the safety and tolerability for Dose-Escalation and Efficacy Study of LAE001/Prednisone and Afuresertib as a combinational therapy in patients with mCRPC who have progressed on, or who are intolerant of, at least 1 prior standard treatment of care.
Qualifications
- Adults ages 18+
- Diagnosed adenocarcinoma of the prostate
- Castration levels of testosterone (<50 ng/dL or 1.7 nom/L)
- No major surgery 28 days prior to study treatment
Compensation
Up to $1,200
Study Duration
6 Months
or click Contact Form below and someone will contact you shortly!